SG Americas Securities’s ClearPoint Neuro CLPT Stock Holding History

SG Americas Securities’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.39M	Buy	+372,356	New	+$4.7M	﹤0.01%	1177
2025 Q4	–	Sell	-5,079	Closed	-$111K	–	3625
2025 Q3	$111K	Buy	+5,079	New	+$59.8K	﹤0.01%	3037
2023 Q4	–	Sell	-16,529	Closed	-$83K	–	3147
2023 Q3	$83K	Buy	+16,529	New	+$98.4K	﹤0.01%	2838
2023 Q2	–	Sell	-14,615	Closed	-$123K	–	2424
2023 Q1	$123K	Buy	+14,615	New	+$128K	﹤0.01%	2779
2021 Q4	–	Sell	-6,479	Closed	-$115K	–	3427
2021 Q3	$115K	Buy	+6,479	New	+$121K	﹤0.01%	3600

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SG Americas Securities's CLPT Position: Q1 2026 in Review

SG Americas Securities opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 372,356 shares worth $3.39M. The stake represents ﹤0.01% of the portfolio and ranks #1177 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in CLPT as recently as Q3 2025.

SG Americas Securities first reported a position in CLPT in Q3 2021 and has held it in 5 quarters since. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

SG Americas Securities held 372,356 shares of ClearPoint Neuro worth $3.39M as of Q1 2026.
ClearPoint Neuro was a new SG Americas Securities position in Q1 2026.
ClearPoint Neuro made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1177 holding.
SG Americas Securities first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 5 quarters since.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.